New hope for stubborn psoriasis: drug targets scalp, nails, and more
Disease control
Ongoing
This study looks at how well the drug tildrakizumab works for psoriasis in difficult areas like the scalp, nails, genitals, and palms. About 120 adults with moderate to severe psoriasis will receive the treatment and be followed for up to 52 weeks. The goal is to see if it improv…
Sponsor: Clin4all • Aim: Disease control
Last updated May 17, 2026 08:05 UTC